Vitreo Retinal Technologies Frequently Asked Questions (FAQ)
When was Vitreo Retinal Technologies founded?
Vitreo Retinal Technologies was founded in 1999.
Where is Vitreo Retinal Technologies's headquarters?
Vitreo Retinal Technologies's headquarters is located at 2 Venture, Irvine.
What is Vitreo Retinal Technologies's latest funding round?
Vitreo Retinal Technologies's latest funding round is Series A.
How much did Vitreo Retinal Technologies raise?
Vitreo Retinal Technologies raised a total of $9.35M.
Who are the investors of Vitreo Retinal Technologies?
Investors of Vitreo Retinal Technologies include De Novo Ventures.
Who are Vitreo Retinal Technologies's competitors?
Competitors of Vitreo Retinal Technologies include Intrinsic Therapeutics, SetPoint Medical, PulmonX, Mobius Therapeutics, Prometheus Laboratories and 7 more.
Compare Vitreo Retinal Technologies to Competitors
Mobius Therapeutics is a commercial stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. The glaucoma indication is in active commercialization; the pterygium and refractive indications are awaiting approval by the Food and Drug Administration.
Medical devices for the treatment of severe gastrointestinal disorders
SetPoint Medical develops implantable bioelectronic therapies to treat chronic inflammatory diseases.. It aims to treat patients with chronic autoimmune diseases and provides a treatment alternative for rheumatoid arthritis, inflammatory bowel disease, and other chronic autoimmune conditions. It was formerly known as Innovative Metabolics. The company was founded in 2007 and is based in Valencia, California.
Femeda is a UK based company focused on development of medical devices to treat incontinence and aims to offer solutions to conditions that can be accessed without visiting a healthcare professional.
Intrinsic Therapeutics develops medical devices. It offers a device to close large defects in the annulus and therapies for soft-tissue injuries of the spine. Intrinsic Therapeutics was formerly known as MedGenesis. The company was founded in 2000 and is based in Woburn, Massachusetts.
Biopticon Corporation is aimed to develop medical diagnostic devices using laser, photonics and image processing based technologies.